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O B J E C T I V E S The aim of this study was to assess the feasibility of real-time computed tomographic
(CT) imaging to guide the percutaneous placement of left ventricular (LV) leads in an animal model.
B A C KG ROUND Cardiac resynchronization therapy has been shown to improve morbidity and
mortality in patients with chronic heart failure. However, placement of the coronary sinus lead can be
challenging and may require a more aggressive surgical approach.
METHOD S Nine swine were placed in a real-time CT scanner to deﬁne the safest percutaneous
access strategy. Under real-time CT guidance, a 3.5-F pacing lead was placed percutaneously in the
anterolateral LV epicardium (n  6 swine) or to the posterolateral wall after the creation of intentional
left pneumothorax (n  3 swine) in a tangential (n  12) or perpendicular (n  1) approach. Pacing
parameters and CT images were assessed during 30-min follow-up. Necropsy ﬁndings were compared
with real-time CT images.
R E S U L T S CT imaging successfully deﬁned the safest percutaneous access route in all 13 lead
placements and guided the therapeutic creation of pneumothoraces. Needle trajectory remained within
5 mm of the access route deﬁned on CT imaging. LV lead placement under CT guidance was successful
in all attempts within 19  7 min. The mean pacing thresholds was 2.5  1.5 V, the mean R wave
amplitude was 11.2  5.6 mV, and the mean impedance was 686  103  and remained unchanged
after tangential placement during 30-min follow-up. Although no cardiac complications were observed
with tangential lead placement (12 of 12), the perpendicular approach resulted in a pericardial effusion
requiring pericardiocentesis. At necropsy, CT images correlated well with the in situ pathological results.
CONC L U S I O N S Percutaneous placement of LV pacing leads under CT guidance is feasible and
might offer an alternative to more invasive surgical approaches in patients with complicated coronary
sinus lead placement. (J Am Coll Cardiol Img 2013;6:96–104) © 2013 by the American College of
Cardiology Foundation
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97ardiac resynchronization therapy using
biventricular pacing has been shown to
decrease morbidity and mortality in pa-
tients with ejection fractions 35%,
QRS-durations 120 ms, and New York Heart
Association (NYHA) class III or IV symptoms
(1–3) and even NYHA class I or II symptoms (4).
However, cardiac resynchronization therapy fails to
provide significant benefit in a substantial minority
(20% to 50%) (5). The placement of a left ventric-
ular (LV) pacing lead via the coronary sinus (CS)
fails in up to 10% because of unsuitable anatomy or
difficult lead delivery (6). Additionally, it limits
potential pacing locations to the areas with acces-
sible CS branches. Areas of myocardial scar, dia-
phragmatic stimulation, and high pacing thresholds
further restrict acceptable lead locations. Conse-
quently, pacing from areas with the best clinical
results might not be attainable (7,8). Although
surgical epicardial lead placement is frequently per-
formed, this approach is associated with higher
morbidity and complication rate.
Real-time percutaneous LV lead placement un-
der computed tomographic (CT) guidance could
potentially overcome these limitations, as it has
demonstrated excellent accuracy and decreased pro-
cedure times in radiological procedures (9).
M E T H O D S
Animal preparation. Nine swine (weight 35 to 40
kg) were injected with 10 mg ketamine intramus-
cularly, intubated, and maintained on 1% to 2%
isoflurane gas (Narkomed, Dragar, Telford, Penn-
sylvania). End-tidal carbon dioxide and electrocar-
diography were monitored throughout. Vascular
access was obtained by percutaneous puncture of
the right femoral vein. All protocols were reviewed
and approved by the Animal Care and Use Com-
mittee and conformed to the guidelines published
in the “Position of the American Heart Association
on Research Animal Use.”
Image-guided LV lead placement. The animals were
brought to a CT scanner with real-time fluoro-
scopic capabilities (either a Siemens Somatom
Plus4 [Siemens Healthcare, Erlangen Germany], a
GE LightSpeed RT 16 [GE Healthcare, Milwau-
kee, WI], or a Philips Brilliance 64 [Philips Med-
ical Systems, Andover, MA]). A contrast-enhanced
scout image (60 ml Omnipaque 300 [GE Health-
care], injection rate 2 ml/s) was used to delineate
the myocardium, identify LV lead target sites, and
evaluate percutaneous access. A second contrastinjection (60 ml Omnipaque 300) was performed in
3 animals after LV lead placement. LV lead place-
ment was performed in the first 6 animals with fully
inflated lungs to the most lateral LV site, which was
percutaneously accessible. In 3 swine, an intentional
left-sided pneumothorax was created after selective
intubation of the right bronchus. In those animals,
the posterolateral target site was arbitrarily defined
as a 5-o’clock location of the LV myocardium in a
short-axis view. A 20-gauge needle was advanced
under real-time CT guidance from a left intercostal
position into the pleural space and room air injected
until the lateral LV free wall.
After delineation of a safe access route, a 17-
gauge spinal needle was advanced percutaneously
across the chest wall toward the epicardium. The
real-time imaging plane was chosen parallel to
the interventional plane to allow full visualization of
the needle. Needle navigation was performed under
real-time CT guidance along the pre-determined
access route. The maximal distance of projected
access route (Fig. 1A) and the actual
needle tip position during access (Fig. 1B)
were measured on the 2-dimensional nav-
igation images to assess the accuracy of
needle navigation.
CT imaging was performed using a
single-scan acquisition or “point-and-
shoot mode” to freeze the cardiac motion
(tube voltage 120 kV, tube current 120 to
200 mA, slice thickness 10 mm, spatial
resolution 0.5 mm3, latency 750 to 1,000
ms) and continuous fluoroscopy mode (tube voltage
120 kV, tube current 50 mA, slice thickness 5 to 10
mm, temporal resolution 6 to 8 frames/s), which
was displayed inside or outside of the procedure
room. After the needle tip was visualized at the
epicardial border, a 3.5-F pacing lead (Medtronic,
Inc., Minneapolis, Minnesota) was advanced to the
needle tip. Electrical signals were recorded with a
Medtronic interrogator (Analysis Mode) at a paper
speed of 25 mm/s. Potential perforation was as-
sessed with attempts to aspirate blood. Under real-
time CT guidance, the needle was advanced tan-
gentially about 10 mm into the myocardium. Once
an intramyocardial position had been obtained as
assessed by CT imaging, repeat electrical ventricular
electrograms were recorded, and the inability to
aspirate blood was confirmed. The 3.5-F pacemaker
lead was advanced into the myocardium and its
helix deployed with 3 to 5 clockwise torquing
motions. Acute R wave, lead impedance, and pac-
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98needle was slowly retracted under CT guidance. In
the 3 animals in which intentional pneumothoraces
had been created, the lung was reinflated after LV
lead placement.
Repeat pacing parameters were measured imme-
diately after needle removal and after a 30-min
waiting period. Follow-up CT imaging was per-
formed 30 min after lead placement to assess the
lead position and possible complications.
After the initial tangential lead placement, the
lead was removed in 4 of the first 6 animals
(without intentional pneumothorax) to assess the
feasibility of repeat pacemaker lead placement. A
CT scan was performed 30 min after lead removal
to assess potential complications before repeat lead
placement.
In 3 of the 4 animals, repeat tangential lead
placement was performed as described. In the
fourth swine, the feasibility of a perpendicular
access route was evaluated. Under real-time CT
guidance, the needle was advanced along a perpen-
dicular trajectory to the epicardium. The needle tip
was advanced about 4 to 5 mm perpendicular to the
epicardial surface into a midmyocardial position
under real-time CT guidance, with repeat electrical
recording and aspiration. Pacemaker lead place-
ment and CT imaging were performed as described
T Imaging–Guided LV Lead Placement
t ventricle as well as myocardium seen in contrast-enhanced comput
orange line (A). Percutaneous needle (black arrow) with tip (white a
l position (white arrows, C). CT images correlate well with left parast
E). Angulated, tangential placement of lead tip seen in C conﬁrmedfor the tangential lead placement.Radiation exposure during the procedure was
calculated on the basis of the dose-length product
(DLP) recorded by the CT scanner.
Postmortem examination. At the end of the experi-
ent, the animals were euthanized using 3 mol/;
otassium chloride solution, and a midline thora-
otomy was performed. The excised heart was
ectioned parallel to the pacemaker lead. Lead entry
oint, entry angle, and length of intramyocardial
ead segment were recorded for later comparison. A
areful inspection for complications was performed.
Statistical analysis. Statistical analysis was per-
ormed using SPSS for Windows release 10.07
SPSS, Inc., Chicago, Illinois). Continuous vari-
bles are expressed as mean  SD unless noted
therwise. Comparisons were performed using a
-tailed, 2-sample t test (analysis of variance).
orrelations were assessed using Pearson’s equa-
ion. Differences were considered significant at a
evel of p  0.05.
R E S U L T S
CT imaging–supported planning of access strategy. In
all 13 attempts, CT imaging allowed the visualiza-
tion of the individual cardiac and pulmonary anat-
omy to plan the access strategy. An anterolateral
entry site avoiding lung tissue was successfully
omographic (CT) image. Projected trajectory for left ventricular
) advanced into the myocardium (B). Implanted pacemaker lead
l access site (black arrow, D) and anterolateral epicardial entry
explanted heart at necropsy (white arrow, F).Figure 1. Real-Time C
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99successful creation of a controlled left-sided pneu-
mothorax under CT guidance, a lateral access site
was chosen in 3 swine (Fig. 2A). The mean dis-
tances from the skin to the epicardial surface were
3.8  1.7 cm and 6.3  1.9 cm in the anterolateral
nd lateral approaches, respectively.
Real-time CT guidance to LV target site. The delivery
eedle could be well visualized compared with the other
ardiac and pulmonary structures. Intravenous contrast
njection aided in the visualization of the myocardium.
Real-time CT was successful in all experiments
o guide the course of the needle from the skin
urface to the epicardium along the planned trajec-
ory. The maximal distance between the intended
oute (Fig. 1A) and actual trajectory (Fig. 1B)
iffered by 5 mm when evaluated by visual assess-
ent and quantitative on-screen measurements.
picardial contact of the needle tip as assessed by
T imaging could be confirmed in all experiments
y the appearance of ventricular signals and the
nability to aspirate blood.
In the 12 tangential approaches (9 initial and 3
Figure 2. Real-Time CT Imaging–Guided Creation of Left-Sided
Needle at left pleural space for creation of intentional pneumothor
posterolateral left ventricular wall (black arrow, B). Percutaneous p
cardium (white arrow, D).epeat placements), the needle was successfully edvanced to a midmyocardial position presenting
0% to 60% of the transmural thickness. Antero-
ateral access was usually successfully achieved dur-
ng the first attempt, while 2 of the 3 lateral
pproaches required a second attempt. Lack of
erforation was confirmed with electrographic re-
ording and aspiration in all cases.
Percutaneous pacing lead delivery. In the 12 tangen-
ial approaches, the 3.5-F lead was successfully
elivered under real-time CT guidance. CT imag-
ng allowed the successful intramyocardial lead tip
lacement (bright metal artifact extending beyond
he needle tip). The delivery needle could be suc-
essfully removed without acute lead dislodgement
n all cases (Fig. 1C). Final intramyocardial place-
ent was confirmed in all 12 tangentially placed
acemaker leads by electrograms and CT imaging
Figs. 1C and 3, Online Video 1).
During the single perpendicular placement, the
eedle was slowly advanced to a midmyocardial
osition representing 6 mm of the 12-mm wall
hickness under real-time visualization. After sev-
umothorax and Posterolateral Lead Placement
hite arrow, A). Left-sided pneumothorax (white arrow, B) pacing le
g lead at necropsy (white arrow, C). Posterolateral lead tip position cPne
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100at the endocardial border, and aspiration of highly
oxygenated blood with an oxygen saturation  95%
confirmed the perforation. After retraction of the
needle, the artifact of the freely moving pacemaker
lead could be visualized in an intracavitary position
(Fig. 4). Electrographic recordings demonstrated
far-field R waves and a lack of capture at 10 V at
0.5 ms. The pacemaker lead was then withdrawn
to a midmyocardial position under real-time CT
guidance.
Total mean procedure time was 19  7 min.
Mean time from percutaneous access to successful
lead delivery was 14  5 min for the 10 anterolat-
eral lead placements and 34  13 min for the
posterolateral lead placement (pneumothorax cre-
ation: 18  6 min; lead placement: 16  7 min).
LV pacing. Successful LV pacing was demonstrated
after all 12 tangential and the perpendicular pace-
maker lead placements (Fig. 5). The mean thresh-
old was 2.2  1.3 V at 0.5 ms (range: 0.7 to 5.0 V),
the mean R-wave amplitude was 10.6  4.8 mV
(range: 5.0 to 20.4 mV), and the mean pacing
impedance was 674  91  (range: 509 to 814 )
(Table 1). No evidence of diaphragmatic or skeletal
muscle stimulation was observed with pacing at 10
V at 0.5 ms. Parameters did not change significantly
before and after removal of the delivery needle
(Table 1). No significant change after a 30-min
follow-up period was seen in the tangentially placed
pacemaker leads. Pacing parameters of the 3 repeat
tangential placements were similar to the 9 initial
tangential placements (Table 1). Midmyocardial
lead placement after the perforation (perpendicular
approach) demonstrated normal immediate R-wave
and pacing threshold, with rapid deterioration due
Left Ventricular Lead Placement
an be easily detected (white arrows, A). Three-dimensional recon-
ved appreciation of cardiac anatomy (B).to a pericardial effusion.CT follow-up. Stable midmyocardial lead position
as observed on CT imaging 30 min after the 12
angential lead placements, and no intrathoracic
emorrhage, unintentional pneumothorax, or peri-
ardial effusions were seen. Unchanged lead posi-
ion on CT imaging was documented after 30 min
n all animals, without significant changes in lead
arameters. A large pericardial effusion was ob-
erved 10 min after the perforation related to the
erpendicular lead placement. A real-time CT
maging–guided pericardiocentesis was successfully
erformed, but the animal was euthanized after
eaccumulation.
Radiation dose. Localization and marker placement
scans accumulated a mean DLP of 140.7  17.5
mGy · cm. Placement of the LV lead scans accu-
mulated a mean DLP of 422.1  23.5 mGy · cm.
Mean total procedure-related DLP was 562.8 
42.8 mGy · cm. This would correspond in a 70-kg
reference patient to an expected whole-body effec-
tive dose of 2.4  0.3 mSv (240 mrem) for
localization and marker placement, 7.2  0.4 mSv
(720 mrem) for placement of the LV lead, and a
total procedural dose of 9.6 0.4 mSv (960 mrem).
Correlation of CT and pathological ﬁndings. The
verall CT location of the epicardial pacing lead
orrelated well with the necropsy findings (Figs. 1
nd 2). Mean distances of the lead tip to the right
entricular–interventricular septal junction were
0  7 and 43  7 mm (range: 29 to 52 mm; p 
.05) by necropsy and CT imaging, respectively.
imilarly, there was a significant relationship be-
ween the intramyocardial pacing lead segment by
T imaging and by pathology (15 2 mm vs. 17
mm, p  0.05) (Fig. 1).
Figure 4. LV Perforation
After perpendicular access (white dotted line) pacing lead isFigure 3. Left Lateral
Intramyocardial lead cseen inside the left ventricular (LV) cavity (white arrow).
cap
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101The pericardial effusion and residual pneumotho-
races diagnosed on CT imaging were confirmed by
necropsy. No other complication was seen in the
other experiments.
D I S C U S S I O N
To our knowledge, this is the first time that real-time
CT imaging has been used to guide any interventional
cardiac procedure. Real-time CT imaging was able to:
Figure 5. Ventricular Capture Threshold
Ventricular pacing at 110 beats/min (left half of panel) with loss of
Table 1. Pacing Parameters Shown for Each of the 12 Lead Imp
Implant
Threshold (V at 0.5 ms)
IMM NR 30 min
1 (AL/T) 2.4 2.3 2.1
2 (AL/T) 0.7 0.7 0.8
3 (AL/T) 5.0 4.7 4.7
4 (AL/T) 2.9 3.0 2.9
5 (AL/T) 2.0 2.3 2.1
6 (AL/T) 1.7 1.6 2.0
7 (PL/T) 3.2 3.0 2.8
8 (PL/T) 0.5 0.5 0.8
9 (PL/T) 1.2 1.1 0.9
10 (AL/T) 0.8 0.8 0.9
11 (AL/T) 3.1 3.3 3.0
12 (AL/P) 2.3 2.3 NA
Mean 2.2 2.1 2.1*
SD 1.3 1.3 1.2
Parameters are shown immediately after ﬁxation of pacing lead (IMM), after need
effusion with no measurements at 30 min (NA). Implants 1 to 9 were initial atte
and 30 min versus NR.
AL  anterolateral lead position; P  perpendicular access; PL  posterolateral le1) define and create (i.e., intentional pneumothorax)
percutaneous access routes to the LV epicardium; 2)
guide initial and repeat LV lead placements with
acceptable pacing parameters; and 3) assess intrapro-
cedural complications.
Clinical CS lead placement. An increasing number of
studies have demonstrated improvements in mor-
bidity and mortality with biventricular pacing in
patients with NYHA class III or IV symptoms,
ejection fractions  35%, and QRS durations 
ture (black arrow) at a threshold of 0.8 V at 0.5 ms.
s
R-Wave Amplitude (mV) Impeda
MM NR 30 min IMM NR
13.9 14.0 14.6 619 632
20.4 20.1 21.2 509 514
6.4 6.4 7.1 721 714
5.0 5.2 4.9 786 762
3.8 3.4 4.5 599 634
7.1 7.8 8.9 705 714
14.6 12.3 9.8 628 601
8.5 8.1 9.4 771 802
9.7 7.8 11.2 583 602
15.9 16.9 15.0 691 684
9.1 10.4 10.4 814 801
7.9 6.8 NA 661 682
10.2 9.9 10.6* 673.9 678
5.0 5.0 4.8 91.2 86
as retracted (NR), and after a 30-min waiting period. Perpendicular placement (imp
, and implants 10 to 12 were repeat placements (see text). *p  0.05 for comparilant
nce ()
I 30 min
599
535
698
771
578
692
590
834
571
703
799
NA
.5 670.0*
.8 102.0
le w lant 7) led to a pericardial
mpts son of 30 min versus IMMad position after intentional pneumothorax; T  tangential.
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102120 or 130 ms (6). Additionally, even some patients
with NYHA class I or II symptoms benefit from
cardiac resynchronization (4).
Although in several studies, intravenous CS lead
placement could not be achieved in up to 10% of
patients (6), this number is further decreasing
because of operator experience and the use of
preprocedural imaging such as CT angiography.
However, difficult anatomy, phrenic nerve capture,
insufficient lead stability, or pacing parameters con-
tinue to be implicated in possible delivery failures
(10). Even after successful CS lead placement,
30% of patients do not experience significant
symptom reduction (5,11). Although early studies
seemed to suggest benefit from a posterolateral lead
position (7,8), recent data from the MADIT-CRT
(Multicenter Automatic Defibrillator Implantation
Therapy With Cardiac Resynchronization Ther-
apy) and COMPANION (Comparison of Medical
Therapy, Pacing, and Defibrillation in Heart Fail-
ure) trials found no difference among anterior,
lateral, and posterior pacing locations (12,13). Im-
portantly, best locations are often defined not ana-
tomically but by viability (“paceability”), and acti-
vation sequences using electrograms or cardiac
ultrasound are able to define areas of late activation
or contraction (8,14,15).
Although minimally invasive surgical approaches
are forthcoming (16,17), this approach is more
invasive and associated with increased morbidity
but can be performed with direct visualization of
the heart (18).
Percutaneous real-time CT imaging–guided approach.
A percutaneous delivery of an LV pacing lead
would theoretically allow the pacing lead delivery at
any chosen LV site, and the lead could be tunneled
subcutaneously to the subclavicular implant loca-
tion. Using real-time CT imaging, the safest and
most promising trajectory could be determined on
the basis of the individual pulmonary and cardiac
anatomy in our experiments. Access routes with no
lung tissue could be selected. Although this resulted
mostly in an anterolateral lead position, this loca-
tion seems to be equivalent to lateral and posterior
lead positions on the basis of MADIT-CRT and
COMPANION results (12,13) and avoided a very
apical position, which was associated with increased
risk for heart failure or death (13). Additionally, our
study demonstrated as proof of concept the ability
to access large parts of the LV free wall after the
creation of a controlled left-sided pneumothorax.
The creation of controlled pneumothoraces has ibeen used successfully for other interventional radi-
ology procedures (19).
For further clinical trials, the development of less
traumatic tools than the needle and pacing lead
used in these experiments is easily conceivable. The
concern of coronary artery injury could be addressed
by performing intraprocedural coronary CT an-
giography. Similarly, delayed enhanced CT images
could be used to define and avoid areas of LV scar.
Importantly, complications such as perforations can
be easily detected and addressed.
To our knowledge, real-time CT imaging has
never been used for any cardiac interventions. How-
ever, several studies have demonstrated the high
utility in various fields, such as interventional radi-
ology and oncology. Real-time CT imaging was
able to accurately guide biopsy, aspiration, drainage,
and ablation in the brain, chest, and abdomen
(20,21). For cardiac applications, real-time CT
imaging offers the unique ability to visualize the
detailed thoracic and cardiac anatomy as well as
interventional tools with submillimeter resolution
and, if needed, high temporal resolution. Different
from real-time magnetic resonance imaging appli-
cations, all devices clinically used and approved by
the U.S. Food and Drug Administration can be
readily used, because heating, electromagnetic sig-
nal noise, and ferromagnetic materials present no
substantial safety concern for real-time CT imag-
ing.
Radiation exposure. When translating the results to
70-kg reference patient, a total effective dose of
.6 mSv is about half that of coronary angioplasty,
quivalent to CT imaging for pulmonary embolism
nd in the range of CT imaging of the liver or
idneys (22–25). This might be acceptable radiation
xposure given the demonstrated mortality and
orbidity benefit of resynchronization therapy. Ad-
itionally, advances in CT technologies, such as
rospective gating, iterative reconstruction, tube
urrent modulation, and low–tube voltage proto-
ols, allow even further dose reductions in new CT
canner systems (26). Especially the variants of
terative image reconstruction currently introduced
nto routine scanning procedures are promising for
rastic dose reductions in the range of 50% and
igher, without significant changes to the achiev-
ble image quality.
Study limitations. Given the scope of this feasibility
tudy, the number of study animals was limited.
dditionally, species-specific differences in LV wall
hickness between swine and humans may also
nfluence the safety of a percutaneous approach.
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103The stability of the pacing parameters was tested
only during a 30-min period and may become less
stable during long-term follow-up. Although com-
plete reinflation of the left-sided intentionally cre-
ated pneumothorax was attempted, the lack of
continuous suction through a chest tube resulted in
a residual pneumothorax.
No exact intracardiac location markers, such as
surgically implanted metal beads, were used to
assess the accuracy of the real-time CT imaging–
guided placement. However, the overall location
(anterolateral or posterolateral wall), septum–to–
lead tip distance, and length of intramyocardial
segment suggest a good correlation between real-
time CT imaging and necropsy findings.
Registration of the 2-dimensional imaging plane
used for needle navigation to the 3-dimensional
imaging matrix would provide additional improvedculation 2001;104:3026–9.
1
1
1
1
1
mal left ventriculafurther to avoid possible complications such as
nerve or vascular damage.
C O N C L U S I O N S
To our knowledge, this is the first study using
real-time CT imaging to guide any cardiac inter-
vention. This study demonstrates the feasibility of
percutaneous LV lead placement, with acceptable
procedure times and good pacing parameters. Real-
time CT imaging allowed planning of the trajec-
tory, visualization of pacing lead deployment, and
early detection of complications. This strategy may
offer an alternative to surgical procedures after failed
attempts at endocardial CS lead placement.
Reprint requests and correspondence: Dr. Timm Dickfeld,
niversity of Maryland, Division of Cardiology, 22 S.
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